IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,580 | -54.3% | 1,226,400 | -29.2% | 0.01% | -44.4% |
| Q2 2023 | $12,198 | +6.4% | 1,732,700 | -7.6% | 0.02% | +20.0% |
| Q1 2023 | $11,459 | -44.0% | 1,875,500 | -41.4% | 0.02% | -46.4% |
| Q4 2022 | $20,454 | -99.7% | 3,200,900 | +295.9% | 0.03% | +154.5% |
| Q3 2022 | $7,746,000 | +50.3% | 808,600 | +199.5% | 0.01% | +83.3% |
| Q4 2021 | $5,154,000 | +15.8% | 270,000 | +92.0% | 0.01% | 0.0% |
| Q1 2021 | $4,451,000 | +298.5% | 140,600 | +129.0% | 0.01% | +500.0% |
| Q3 2019 | $1,117,000 | – | 61,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |